Position in ALVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37
-$2,964 QoQ
Shares Held
11
-98.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $112,181,802 across 35 Drug Manufacturers - Specialty & Generic names. ALVO ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
54,824 | $32,509,535 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
595,032 | $17,922,363 | |
| 3 | ZTS |
Zoetis Inc.
|
133,497 | $15,780,680 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
94,379 | $12,433,489 | |
| 5 | VTRS |
Viatris Inc
|
627,641 | $8,479,429 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
213,321 | $5,104,771 | |
| 7 | ALKS |
Alkermes plc.
|
66,815 | $2,362,578 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
30,814 | $2,337,241 |
All Filings in ALVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37 | 11 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,001 | 585 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,791 | 585 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,907 | 867 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,931 | 1,027 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||